Stock Fundamentals

Company Information

▼
Company Name
Dyne Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US26818M1080
CIK: 0001379895
CUSIP: 26817G300
Currency: USD
Full Time Employees: 240
Phone: 781 786 8230
Website: https://www.dyne-tx.com
Fiscal Year End: December
IPO Date: Sep 17, 2020
Description:

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Address:

1560 Trapelo Road, Waltham, MA, United States, 02451

Directors & Officers

▼
Name Title Year Born
Mr. John G. Cox M.B.A. CEO, President & Director 1963
Dr. Oxana Beskrovnaya Ph.D. Chief Innovation Officer 1961
Ms. Johanna Friedl-Naderer Chief Commercial Officer 1968
Dr. Douglas Kerr M.B.A., M.D., Ph.D. Chief Medical Officer 1967
Mr. Erick J. Lucera C.F.A., CPA CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer 1968
Dr. Axel Wiest Senior VP and Head of Portfolio Strategy & Operations NA
Dr. Rajesh Manchanda Ph.D. Chief Technical Officer 1966
Mr. James P. Bilotta M.B.A. Chief Digital & Information Officer NA
Mr. Daniel Wilson Senior VP & Head of Legal 1972
Ms. Lucia Celona Chief Human Resource Officer 1966

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
HHG PLC 14.75M Sep 30, 2025 8.96% $0.09 56.24%
Vanguard Group Inc 11.22M Dec 31, 2025 6.81% $0.00 14.91%
BlackRock Inc 9.63M Sep 30, 2025 5.85% $0.00 19.27%
Atlas Venture Life Science Advisors, LLC 9.13M Dec 31, 2025 5.55% $20.64 0.00%
JPMorgan Chase & Co 6.73M Sep 30, 2025 4.09% $0.00 118.04%
FMR Inc 6.57M Dec 31, 2025 3.99% $0.01 21.62%
FCPM III SERVICES BV 5.46M Sep 30, 2025 3.32% $13.81 0.00%
State Street Corp 5.27M Sep 30, 2025 3.20% $0.00 57.02%
Adage Capital Partners Gp LLC 5.17M Dec 31, 2025 3.14% $0.15 45.53%
Orbis Allan Gray Ltd 4.80M Dec 31, 2025 2.92% $0.39 0.00%
TCG Crossover Management, LLC 4.62M Sep 30, 2025 2.80% $2.87 22.53%
Siren, L.L.C. 3.50M Dec 31, 2025 2.13% $2.04 -25.93%
Citadel Advisors Llc 3.41M Sep 30, 2025 2.07% $0.01 261.64%
Armistice Capital, LLC 3.25M Dec 31, 2025 1.97% $0.76 6.06%
Frazier Life Sciences Management, L.P. 3.15M Dec 31, 2025 1.92% $1.66 16.00%
Marshall Wace Asset Management Ltd 3.01M Sep 30, 2025 1.83% $0.04 572.92%
Geode Capital Management, LLC 2.87M Sep 30, 2025 1.74% $0.00 27.24%
T. Rowe Price Investment Management,Inc. 2.81M Sep 30, 2025 1.71% $0.02 56.80%
Vivo Capital, LLC 2.61M Dec 31, 2025 1.59% $3.31 0.00%
Logos Global Management LP 2.40M Sep 30, 2025 1.46% $2.72 26.32%

Shares Statistics

▼
Shares Outstanding: 164.65M
Shares Float: 134.21M
% Insiders: 73.50%
% Institutions: 11,261.10%
Short % Float: 12.78%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 HHG PLC 14.75M 8.96% ▲ 56.24% Sep 30, 2025
2 Vanguard Group Inc 11.22M 6.81% ▲ 14.91% Dec 31, 2025
3 BlackRock Inc 9.63M 5.85% ▲ 19.27% Sep 30, 2025
4 Atlas Venture Life Science Advisors, LLC 9.13M 5.55% ▲ 0.00% Dec 31, 2025
5 JPMorgan Chase & Co 6.73M 4.09% ▲ 118.04% Sep 30, 2025
6 FMR Inc 6.57M 3.99% ▲ 21.62% Dec 31, 2025
7 FCPM III SERVICES BV 5.46M 3.32% ▲ 0.00% Sep 30, 2025
8 State Street Corp 5.27M 3.20% ▲ 57.02% Sep 30, 2025
9 Adage Capital Partners Gp LLC 5.17M 3.14% ▲ 45.53% Dec 31, 2025
10 Orbis Allan Gray Ltd 4.80M 2.92% ▲ 0.00% Dec 31, 2025

Valuation Metrics

▼
Enterprise Value: $1.90B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $2.57B
EBITDA: $-447.18M
PEG Ratio: $0.19
Book Value: $4.85
Earnings/Share: $-3.62
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -34.32%
ROE (TTM): -60.66%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 15.60x 0.01x 0.09x N/A -0.02x
2023-12-31 2.53x 0.05x 0.45x N/A -0.02x
2022-12-31 9.46x 0.02x 0.18x -58.61x -0.03x
2021-12-31 13.31x 0.01x 0.14x -202.19x -0.03x
2020-12-31 31.83x 0.00x 0.03x -148.10x 0.00x
2019-12-31 6.26x 0.00x 0.15x -47.68x 0.00x
2018-12-31 11.47x 0.00x 1.59x -959.00x 0.00x
2017-12-31 1.45x 0.06x 0.84x -0.67x 0.11x
2016-12-31 3.26x 0.10x 0.84x -1.02x 1.90x
2015-12-31 2.40x 0.03x 0.75x 0.12x 0.11x
2014-12-31 3.93x 0.01x 0.73x -4.75x 0.11x
2013-12-31 2.34x 0.01x 0.58x -3.28x 0.09x
2012-12-31 3.01x 0.01x 0.45x N/A 0.26x
2011-12-31 4.23x 0.00x 0.73x -0.66x 0.00x
2010-12-31 1.43x 0.05x 0.73x -0.03x 0.20x
2009-12-31 1.10x 0.28x 0.73x -2.01x -4.66x
2008-12-31 1.65x 0.01x 0.68x 1.66x 0.07x
2007-12-31 1.66x 0.01x 0.66x 1.58x 0.06x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 05, 2025 John Cox N/A Sale 2.64K $13.41 $35.40K
Jul 14, 2025 John Cox N/A Purchase 100.00K $9.11 $911.00K
Mar 13, 2025 Johanna Friedl-Naderer N/A Sale 143.00 $12.12 $1.73K
Mar 11, 2025 Oxana Beskrovnaya N/A Sale 2.15K $11.38 $24.50K
Mar 11, 2025 Richard William Scalzo N/A Sale 1.34K $11.38 $15.28K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DYN.US!